Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases
Helge C Dorfmueller1, Vladimir S Borodkin, Marianne Schimpl
1Division of Molecular Microbiology, College of Life Sciences, University of Dundee, Dundee DD15EH, Scotland.
Abstract:
Posttranslational modification of metazoan nucleocytoplasmic proteins with N-acetylglucosamine (O-GlcNAc) is essential, dynamic, and inducible and can compete with protein phosphorylation in signal transduction. Inhibitors of O-GlcNAcase, the enzyme removing O-GlcNAc, are useful tools for studying the role of O-GlcNAc in a range of cellular processes. We report the discovery of nanomolar OGA inhibitors that are up to 900,000-fold selective over the related lysosomal hexosaminidases. When applied at nanomolar concentrations on live cells, these cell-penetrant molecules shift the O-GlcNAc equilibrium toward hyper-O-GlcNAcylation with EC₅₀ values down to 3 nM and are thus invaluable tools for the study of O-GlcNAc cell biology.
Related Concept Videos
Lysosomal Hydrolases
Inhibitors of Gram-positive Cell Wall Synthesis
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release


